AFT Pharmaceuticals Ltd (ASX:AFP)

A$ 2.55 -0.02 (-0.78%) Market Cap: 247.03 Mil Enterprise Value: 265.29 Mil PE Ratio: 18.46 PB Ratio: 3.31 GF Score: 88/100

AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 03, 2023
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 01, 2023
Full Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 21, 2023

Earnings
Half Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 23, 2022

A$3.44

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 04, 2022
Full Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 22, 2022

Earnings
Half Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 17, 2021

A$4.58 (+1.78%)

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 05, 2021
Full Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 23, 2021

Earnings
Half Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 18, 2020

A$5.1 (+2.41%)

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Sep 07, 2020
Full Year 2020 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 19, 2020

A$4.08 (+6.53%)

Earnings
Interim 2020 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 20, 2019

A$2.68

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 01, 2019
Preliminary 2019 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 21, 2019

A$2.4

Earnings

Full Year 2020 AFT Pharmaceuticals Ltd Earnings Call Transcript

May 19, 2020 / 10:00PM GMT

Release Date Price: A$4.08 (+6.53%)

Transcript

Operator

Thank you for standing by, and welcome to the AFT Pharmaceuticals Annual Results Analyst Briefing. (Operator Instructions) I would now like to hand the conference over to Malcolm Tubby, CFO. Please go ahead.

Malcolm Tubby

AFT Pharmaceuticals Limited - CFO & Company Secretary

Thanks, Rachel, and good morning, everybody. Thank you for joining us. Just making sure everybody has the presentation in front of them. If you go to the NZX website, to the AFT instrument, go to announcements, and at the follow of the announcement, you'll see the 4 downloads. And if you need it, the second one down is the results presentation.

So I'll hand over to Hartley now. We'll just do a slow intro, just to make sure you guys have got that in front of you. Thank you.

Hartley Atkinson

AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director

Thank you, Malcolm. My name is Hartley Atkinson, I'm the founder and CEO of AFT Pharmaceuticals. Here today to present FY '20 full year financial results. So as Malcolm has

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.